Mapping of the health of the Nation Outcomes Scale (HoNOS) and Positive and Negative Symptom Scale (PANSS) to the EQ-5D-3L in psychosis patients using the PHAMOUS study [0.03%]
利用PHAMOUS研究将精神疾病患者的健康结果量表（HoNOS）和阳性与阴性症状量表（PANSS）映射到EQ-5D-3L中
Anne Kleijburg,Ben Wijnen,Wouter den Hollander et al.
Anne Kleijburg et al.
Objectives: When health outcomes relevant for economic evaluations are unavailable, algorithms can be developed to map utilities using available clinical outcome measures. This study aims to develop two mapping algorithms...
Correction [0.03%]
改正通知书
Content and cost of waste pharmaceuticals collected by pharmacies for disposal [0.03%]
药店收集待处置的废弃药物及其处理成本分析
Mehmet Akif Erişen,Mesut Ardıç
Mehmet Akif Erişen
Background: The research aims to the costs and contents of waste pharmaceuticals collected through pharmacies for disposal. This study adds significant value to the country's economy in terms of cost and number of medicin...
Cost-effectiveness analysis of atezolizumab plus bevacizumab and chemotherapy for the treatment of metastatic, persistent, or recurrent cervical cancer (BEATcc) [0.03%]
阿特珠单抗联合贝伐珠单抗和化疗治疗转移性、持续性或复发性宫颈癌的性价比分析（BEATcc研究）
Yixiao Zhu,Fenghao Shi,Huiting Lin et al.
Yixiao Zhu et al.
Background: The addition of atezolizumab to bevacizumab plus platinum regimen has demonstrated notable improvements in treating metastatic, persistent, or recurrent cervical cancer, but its cost-effectiveness requires fur...
Saco J de Visser,Adam F Cohen
Saco J de Visser
Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors in the treatment of chronic kidney disease: a systematic review [0.03%]
钠葡萄糖共转运蛋白2抑制剂治疗慢性肾脏病的成本效果系统评价
Anh Thi Ngoc Toan,Toi Lam Phung,Thao Thi Dang et al.
Anh Thi Ngoc Toan et al.
Introduction: Chronic kidney disease (CKD) is a severe, progressive condition with a significant economic burden. We performed a systematic review to assess the cost-effectiveness of sodium-glucose cotransporter 2 (SGLT2)...
Time from approval to reimbursement recommendations in healthcare systems with centralized HTA processes. Focus on the Polish HTA agency [0.03%]
集中式HTA流程的医疗卫生系统中从审批到报销建议的时间。重点是波兰的HTA机构
Aneta Mela,Andrzej Tysarowski,Elżbieta Rdzanek et al.
Aneta Mela et al.
Background: To analyze the time from drug registration to reimbursement recommendations, we examined medicinal products, including new clinical indications, registered by the EMA between 2014 and 2019 across various thera...
A methodological guide for implementing and interpreting results of probabilistic analysis [0.03%]
概率分析实施和结果解读的方法指南
Xuanqian Xie,Alexis K Schaink,Olga Gajic-Veljanoski et al.
Xuanqian Xie et al.
Introduction: Probabilistic analysis, also referred to as probabilistic sensitivity analysis (PSA), is used extensively in cost-effectiveness evaluations of health technologies. We present methodological guidance for impl...
A cost-effectiveness analysis of RefluxStop against relevant therapeutic alternatives for chronic gastroesophageal reflux disease in Sweden [0.03%]
与瑞典治疗慢性胃食管反流病的其他疗法相比，RefluxStop的成本效益分析研究
Sam Harper,Muralikrishnan Kartha,Stuart Mealing et al.
Sam Harper et al.
Introduction: The standard treatment for gastroesophageal reflux disease (GERD) is proton pump inhibitors (PPIs). In selected cases, Nissen fundoplication is offered as a surgical treatment option, but alternative endosco...
An early economic analysis of medical cannabis for the treatment of chronic pain [0.03%]
医用大麻治疗慢性疼痛的早期经济分析
Shanna Marrinan,Anne K Schlag,Michael Lynskey et al.
Shanna Marrinan et al.
Background: Cannabis-based medicinal products (CBMPs) are increasingly demonstrating effectiveness in treating a wide range of conditions, with a relatively high safety profile in clinical usage compared to other prescrip...